Hernández-Valencia M

Language: Spanish
References: 24
Page: 383-388
PDF size: 115.20 Kb.

ABSTRACT

Phosphorilation of subunit b from insulin receptor induced mainly by insulin, it begins a series of intracellular complex signaling in cascade. Through this way establish multiple effects, which permits to the cell initiate its biological activity. This activity include the glucose metabolism, the regulation of ions and amino acids transport, lipids metabolism, glycogen synthesis, genetic transcription, mRNA expression, synthesis and degradation of proteins, as well as synthesis of DNA. Therefore, a modification in anyone of the proteins involved in the insulin signaling, can take place a dysfunction in the glucose metabolism. The impaired glucose can be due because there are many proteins, ions and enzymes that participate in the downstream pathways of the insulin signaling, it has become difficult to find a single phatophysiologic level as cause of diabetes. In spite of the advances in the study of this disease, it has been reached the conclusion that the glucose control is not enough to impede the complications that characterize to type 2 diabetes, since the organic worsening does not stop, which indicates that insulin signaling dysfunction is directly involved in all cellular process, and a better understanding in the communication ways of this hormone will take to new forms of treatment to impaired insulin response.

REFERENCES

1. Patti ME, Kahn CR. The insulin receptor - a critical link in glucose homeostasis and insulin action. JBC Phys Pharm 1998;9:89-109.

2. Brownlee M. The pathobiology of diabetic compli-cations. A unifying mechanism. Diabetes 2005;54: 1615-1625.

3. Fukui K, Wada T, Kagawa S, Nagira K, Ikubo M, Ishihara H, Kobayashi M, Sasaoka T. Impact of the liver-specific expression of SHIP2 (SH 2-containing inositol 5´-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 2005;54: 1958-1967.

4. Spaks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. A high-fat diet coordinately downregulates genes required for mitocondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005;54:1926-1933.

5. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlance WV, Bonadonna R. b-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005;54:1735-1743.

6. Backer JM, Kahn CR, Cahill DA, Ullrich A, White MF. Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamem-brane region of the insulin receptor b-subunit. J Biol Chem 1990;265:16450-16454.

7. Coppack SW, Chinkes DL, Miles JM, Patterson BW, Klein S. A multicompartmental model of in vivo adipose tissue glycerol kinetics and capillary permeability in lean and obese humans. Diabetes 2005;54:1934-1941.

8. Tavare JM, Siddle K. Mutational analysis of insulin receptor function: consensus and controversy. Biochem Biophys Acta 1993;1178:21-39.

9. De Meyts P, Urso B, Christoffersen CT, Shymko RM. Mechanism of insulin and IGF-1 receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling. Ann NY Acad Sci 1995;766:388-401.

10. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson RS, Kahn RC. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 1994;372:186-190.

11. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn RC. 4PS/Insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 1995;42:24670-24673.

12. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retro-viral oncogene encoding a serine-threonine kinase containing an SH-like region. Science 1991;254: 274-277.

13. Kerouz NJ, Horsch D, Pons S, Kahn CR. Differ-ential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 1997;100: 3164-3172.

14. Horsch D, Kahn R. Region-specific mRNA expression of phosphatidylinositol 3-kinase regu-latory isoforms in the central nervous system of C57BL/6J mice. J Comp Neurol 1999;415:105-120.

15. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999;253:210-229.

16. Hernández-Valencia M, Zárate A. El peso fetal al nacimiento como factor de riesgo predisponente para diabetes tipo 2 en la vida adulta. Ginecol Obstet Mex 2001;69:390-398.

17. Ludwing T, Eggenschwiller J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in IGF2 and IGF1r null backgrounds. Dev Biol 1996;177:517-535

18. Hernández-Valencia M, Zárate A, Ochoa R, Fonseca ME, Amato D, Ortiz MJ. IGF-1, EGF and TGF-b expression and their association with intrauterine fetal growth retardation, such as development during human pregnancy. Diabetes Obes Metab 2001;3:1-6.

19. Hernández-Valencia M, Jiménez-Chillaron JC, Reamer C, Fisher S, Joszi A, Hirshman M, et al. B-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes. A murine model. Diabetes 2005;54:702-711.

20. Smith-Hall J, Pons S, Patti ME, Burks DJ, Yenush L, Sun XJ, Kahn R, White MF. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 1997; 36:8304-8310.

21. Patti ME, Kahn CR. Transgenic animal models: insights into the pathophysiology of NIDDM. Diabetes Rev 1997;5:149-163.

22. Zárate A, Hernández-Valencia M, Tene CE. Im-pacto clínico de la resistencia a la insulina y la rela-ción con la prevención de diabetes mellitus. Gac Med Mex 1998;134:647-649.

23. Padrón ML, Hernández MI, Cervera-Aguilar R, Ayala AR. Correlación de dos fórmulas para calcular insulinorresistencia. Ginecol Obstet Mex 2001;69: 233-238.

24. Haffner S, González C, Mettinen H, Kennedy E, Stern M. A prospective analysis of the HOMA Model. Diabetes Care 1996;19:1138-1141.